1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Latent TB Detection Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Latent TB Detection Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Latent TB Detection Market Regional Analysis
6.2 Europe Latent TB Detection Market Revenue 2018-2027 (US$ Million)
6.3 Europe Latent TB Detection Market Forecast Analysis
7. Europe Latent TB Detection Market Analysis – by Test
7.1 Tuberculin Skin Test
- 7.1.1 Overview
- 7.1.2 Tuberculin Skin Test: Europe Latent TB Detection Market – Revenue and Forecast, 2018-2027 (US$ Million)
7.2 Interferon Gamma Released Assay
- 7.2.1 Overview
- 7.2.2 Interferon Gamma Released Assay: Europe Latent TB Detection Market – Revenue and Forecast, 2018-2027 (US$ Million)
8. Europe Latent TB Detection Market Analysis – by End User
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Europe Latent TB Detection Market – Revenue and Forecast, 2018-2027 (US$ Million)
8.2 Diagnostic Centers
- 8.2.1 Overview
- 8.2.2 Diagnostic Centers: Europe Latent TB Detection Market – Revenue and Forecast, 2018-2027 (US$ Million)
8.3 Laboratories
- 8.3.1 Overview
- 8.3.2 Laboratories: Europe Latent TB Detection Market – Revenue and Forecast, 2018-2027 (US$ Million)
9. Europe Latent TB Detection Market – Europe Analysis
9.1 Overview
9.2 Europe
- 9.2.1 Europe Latent TB Detection Market Breakdown, by Key
Country, 2021 and 2027 (%)
- 9.2.1.1 Europe Latent TB Detection Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 UK:
Europe Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.1.1 UK: Europe Latent TB Detection Market Breakdown, by Test
- 9.2.1.1.2 UK: Europe Latent TB Detection Market Breakdown, by End User
- 9.2.1.2 Germany:
Europe Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.2.1 Germany: Europe Latent TB Detection Market Breakdown, by Test
- 9.2.1.2.2 Germany: Europe Latent TB Detection Market Breakdown, by End User
- 9.2.1.3 France:
Europe Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.3.1 France: Europe Latent TB Detection Market Breakdown, by Test
- 9.2.1.3.2 France: Europe Latent TB Detection Market Breakdown, by End User
- 9.2.1.4 Russia:
Europe Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.4.1 Russia: Europe Latent TB Detection Market Breakdown, by Test
- 9.2.1.4.2 Russia: Europe Latent TB Detection Market Breakdown, by End User
- 9.2.1.5 Italy:
Europe Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.5.1 Italy: Europe Latent TB Detection Market Breakdown, by Test
- 9.2.1.5.2 Italy: Europe Latent TB Detection Market Breakdown, by End User
- 9.2.1.6 Rest of Europe:
Europe Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.6.1 Rest of Europe: Europe Latent TB Detection Market Breakdown, by Test
- 9.2.1.6.2 Rest of Europe: Europe Latent TB Detection Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Abbott
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 ARKRAY, Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 BD
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 bioMerieux SA
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 F. HOFFMANN-LA ROCHE LTD.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Lionex GmbH
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Oxford Immunotec Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 QIAGEN
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Serum Institute of India Pvt. Ltd.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For Europe Latent TB Detection Market
